Eli Lilly (Enzastaurin) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Eli Lilly (Enzastaurin) General Information

Description

Enzastaurin is an enzyme inhibitor. Enzastaurin is an investigational oral molecule, threonine kinase inhibitor of the PKC beta and AKT pathways which diffuses B-cell lymphoma.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Lilly Corporate Center
  • Indianapolis, IN 46285
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Acquirer
Denovo Biopharma
Corporate Office
  • Lilly Corporate Center
  • Indianapolis, IN 46285
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Eli Lilly (Enzastaurin) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Eli Lilly (Enzastaurin)‘s full profile, request access.

Request a free trial

Eli Lilly (Enzastaurin) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Eli Lilly (Enzastaurin)‘s full profile, request access.

Request a free trial

Eli Lilly (Enzastaurin) FAQs

  • Where is Eli Lilly (Enzastaurin) headquartered?

    Eli Lilly (Enzastaurin) is headquartered in Indianapolis, IN.

  • What industry is Eli Lilly (Enzastaurin) in?

    Eli Lilly (Enzastaurin)’s primary industry is Buildings and Property.

  • Is Eli Lilly (Enzastaurin) a private or public company?

    Eli Lilly (Enzastaurin) is a Private company.

  • What is Eli Lilly (Enzastaurin)’s current revenue?

    The current revenue for Eli Lilly (Enzastaurin) is .

  • Who are Eli Lilly (Enzastaurin)’s investors?

    Lilly USA has invested in Eli Lilly (Enzastaurin).

  • When was Eli Lilly (Enzastaurin) acquired?

    Eli Lilly (Enzastaurin) was acquired on 16-Sep-2014.

  • Who acquired Eli Lilly (Enzastaurin)?

    Eli Lilly (Enzastaurin) was acquired by Denovo Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process